OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 86 citing articles:

The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas
Rein Willemze, Lorenzo Cerroni, Werner Kempf, et al.
Blood (2019) Vol. 133, Iss. 16, pp. 1703-1714
Open Access | Times Cited: 1154

Cutaneous T‐cell lymphoma: 2017 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2017) Vol. 92, Iss. 10, pp. 1085-1102
Open Access | Times Cited: 141

Cutaneous T‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2015) Vol. 91, Iss. 1, pp. 151-165
Open Access | Times Cited: 139

Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2019) Vol. 94, Iss. 9, pp. 1027-1041
Open Access | Times Cited: 119

Cutaneous pseudolymphoma—A review on the spectrum and a proposal for a new classification
Christina Mitteldorf, Werner Kempf
Journal of Cutaneous Pathology (2019) Vol. 47, Iss. 1, pp. 76-97
Open Access | Times Cited: 104

Cutaneous lymphomas—An update 2019
Werner Kempf, Anne‐Katrin Zimmermann, Christina Mitteldorf
Hematological Oncology (2019) Vol. 37, Iss. S1, pp. 43-47
Open Access | Times Cited: 86

Cutaneous T‐cell lymphomas—An update 2021
Werner Kempf, Christina Mitteldorf
Hematological Oncology (2021) Vol. 39, Iss. S1, pp. 46-51
Open Access | Times Cited: 68

Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2022) Vol. 98, Iss. 1, pp. 193-209
Open Access | Times Cited: 52

Cutaneous T‐cell lymphoma: 2014 Update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2014) Vol. 89, Iss. 8, pp. 837-851
Open Access | Times Cited: 67

Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways
Kalyani Patil, Shilpa Kuttikrishnan, Abdul Quaiyoom Khan, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 382-399
Open Access | Times Cited: 42

Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy
Nuria García‐Díaz, Miguel Á. Piris, Pablo L. Ortiz‐Romero, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1931-1931
Open Access | Times Cited: 38

Cutaneous T‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2021) Vol. 96, Iss. 10, pp. 1313-1328
Open Access | Times Cited: 38

Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets
Ieva Saulīte, Wolfram Hoetzenecker, Stephan Weidinger, et al.
BioMed Research International (2016) Vol. 2016, pp. 1-15
Open Access | Times Cited: 40

Cutaneous B‐cell lymphomas: 2021 update on diagnosis, risk‐stratification, and management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
American Journal of Hematology (2020) Vol. 95, Iss. 10, pp. 1209-1213
Open Access | Times Cited: 39

Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome
Pietro Quaglino, Paolo Fava, Alessandro Pileri, et al.
Journal of Investigative Dermatology (2020) Vol. 141, Iss. 3, pp. 484-495
Open Access | Times Cited: 35

Anti-CD30 antibody–drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives
H. Miles Prince, Martin Hutchings, Eva Domingo‐Domènech, et al.
Annals of Hematology (2022) Vol. 102, Iss. 1, pp. 13-29
Open Access | Times Cited: 20

Mogamulizumab‐associated rash – Case series and review of the literature
Inga Hansen, Finn Abeck, Anne Menz, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 8, pp. 1079-1086
Open Access | Times Cited: 4

Antibody–Drug Conjugates Targeting CD30 in T-Cell Lymphomas: Clinical Progression and Mechanism
Yi Jiang, Sai Dong, Yang Wang
Cancers (2025) Vol. 17, Iss. 3, pp. 496-496
Open Access

The fifth edition of the WHO classification of mature T cell, NK cell and stroma-derived neoplasms
Ayoma D. Attygalle, Kennosuke Karube, Yoon Kyung Jeon, et al.
Journal of Clinical Pathology (2025), pp. jcp-210074
Closed Access

The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas
Liang Lin, Gabriele Roccuzzo, Yuliya Yakymiv, et al.
Cells (2025) Vol. 14, Iss. 4, pp. 309-309
Open Access

Les lésions T folliculaires helper et « mimickers » en dermatopathologie : de la théorie à la pratique
Fanny Beltzung, Marie‐Laure Jullié, Nicolás Ortonne, et al.
Annales de Pathologie (2025)
Closed Access

The biomarker landscape in mycosis fungoides and Sézary syndrome
Brittany Dulmage, Larisa J. Geskin, Joan Guitart, et al.
Experimental Dermatology (2016) Vol. 26, Iss. 8, pp. 668-676
Open Access | Times Cited: 30

Sézary syndrome: old enigmas, new targets
Jan P. Nicolay, Moritz Felcht, Kai Schledzewski, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2016) Vol. 14, Iss. 3, pp. 256-264
Open Access | Times Cited: 28

Page 1 - Next Page

Scroll to top